Market Realist |
FDA Will Review Teva's BLA for Asthma Drug Reslizumab
Market Realist Interleukin-5 is a key cytokine involved in the maturation, recruitment, and activation of eosinophils, which are inflammatory white blood cells implicated in a number of diseases, such as asthma. Elevated levels of blood eosinophils are a risk factor … |
View full post on asthma – Google News